<SEC-DOCUMENT>0001213900-26-031492.txt : 20260319
<SEC-HEADER>0001213900-26-031492.hdr.sgml : 20260319
<ACCEPTANCE-DATETIME>20260319062229
ACCESSION NUMBER:		0001213900-26-031492
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20260319
FILED AS OF DATE:		20260319
DATE AS OF CHANGE:		20260319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Radiopharm Theranostics Ltd
		CENTRAL INDEX KEY:			0001949257
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41621
		FILM NUMBER:		26772298

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		LEVEL 3, 62 LYGON STREET
		CITY:			CARLTON VIC
		PROVINCE COUNTRY:   	C3
		ZIP:			3053
		BUSINESS PHONE:		61 3 9824 5254

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		LEVEL 3, 62 LYGON STREET
		CITY:			CARLTON VIC
		PROVINCE COUNTRY:   	C3
		ZIP:			3053
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0282554-6k_radio.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Form 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the Month of March 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Commission File Number: 001-41621</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>RADIOPHARM THERANOSTICS LIMITED</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name of Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>Level 3, 62 Lygon Street, Carlton South,
Victoria, 3053, Australia</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F &#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether by furnishing the
information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes &#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
&#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If &ldquo;Yes&rdquo; is marked, indicate below
the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RADIOPHARM THERANOSTICS LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>EXPLANATORY NOTE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Radiopharm Theranostics Limited (the &ldquo;Company&rdquo;)
published one announcement (the &ldquo;Public Notice&rdquo;) to the Australian Securities Exchange on March 19, 2026 titled:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RAD
to present at NWR Virtual Healthcare Conference&rdquo;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A copy of the Public Notice is attached as an exhibit to this report
on Form 6-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This report on Form 6-K (including the exhibit
hereto) shall not be deemed to be &ldquo;filed&rdquo; for purposes of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be
expressly set forth by specific reference in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#8239;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 9%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B> <BR>
<B>Number</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 90%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea028255401ex99-1.htm">RAD to present at NWR Virtual Healthcare Conference</A>&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#8239;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RADIOPHARM THERANOSTICS LIMITED</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 19, 2026</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 37%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Phillip Hains</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phillip Hains</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Secretary</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#8239;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea028255401ex99-1.htm
<DESCRIPTION>RAD TO PRESENT AT NWR VIRTUAL HEALTHCARE CONFERENCE
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: normal bold 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><B>ASX ANNOUNCEMENT</B><BR>
<B>19 March 2026</B></TD>
  <TD STYLE="text-align: right; width: 50%"><IMG SRC="ea028255401_ex99-1img1.jpg" ALT="" STYLE="height: 79px; width: 216px"></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white"><B>Radiopharm
to present at NWR Virtual Healthcare Conference</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sydney, Australia&ndash; 19 March 2026 &ndash; Radiopharm Theranostics
(ASX: RAD, &ldquo;Radiopharm&rdquo; or the &ldquo;Company&rdquo;), a clinical-stage biopharmaceutical company focused on developing innovative
oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that it will present at the NWR Virtual Healthcare
Conference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CEO &amp; Managing Director Riccardo Canevari will present at <B>8:30am
AEDT on Wednesday 25 March 2026</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shareholders, investors and interested parties are encouraged to register
to attend the presentation at the following link: https://us02web.zoom.us/webinar/register/WN_WlOvxNAQRImgmoTV07BUsA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A recording will be available at the above link shortly after the conclusion
of the live session, and the replay will also be available via the Company&rsquo;s website and social media channels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Questions can be submitted on the day or sent in advance to matt@nwrcommunications.com.au</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For more information please visit: https://nwrcommunications.com/healthconf</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Radiopharm Theranostics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Radiopharm Theranostics is a clinical stage radiotherapeutics
company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas
of high unmet medical need. Radiopharm is listed on ASX (RAD) and on NASDAQ (RADX). The company has a pipeline of distinct and highly
differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program
includes one Phase 2 and four Phase 1 trials in a variety of solid tumor cancers including lung, breast, and brain metastases. Learn
more at radiopharmtheranostics.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Authorised on behalf of the Radiopharm Theranostics board of directors
by Chairman Paul Hopper.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For more information:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>Riccardo Canevari<BR>
CEO &amp; Managing Director<BR>
P: +1 862 309 0293<BR>
E: rc@radiopharmtheranostics.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>Radiopharm Theranostics
Limited<BR>
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia<BR>
ABN: 57 647 877 889</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><B>ASX ANNOUNCEMENT</B><BR>
<B>19 March 2026</B></TD>
  <TD STYLE="text-align: right; width: 50%"><IMG SRC="ea028255401_ex99-1img1.jpg" ALT="" STYLE="height: 79px; width: 216px"></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Anne Marie Fields</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Precision AQ (Formerly Stern IR)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E: annemarie.fields@precisionaq.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Paul Hopper<BR>
Executive Chairman<BR>
P: +61 406 671 515<BR>
E: paulhopper@lifescienceportfolio.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Media</U><BR>
Matt Wright<BR>
NWR Communications<BR>
P: +61 451 896 420<BR>
E: matt@nwrcommunications.com.au</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>Radiopharm Theranostics
Limited<BR>
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia<BR>
ABN: 57 647 877 889</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ea028255401_ex99-1img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea028255401_ex99-1img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !/ -@# 2(  A$! Q$!_\0
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;5HENC%@I)S@#DDD\#@#)Z=JL44 %%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
